基本信息
cas:405169-16-6
中文名称:多韦替尼
中文别名:TKI258;4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮;CHIR-258;
英文名称:Dovitinib
英文别名:4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one;4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one;Dovitinib (TKI-258,CHIR-258);4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one;Unii-I35H55G906;Dovitinib (TKI-258, CHIR-258);4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one;4-amino-5-fluoro-3-[6-(4-methyl-piperazin-1-yl)-1H-benzoimidazol-2-yl]-1H-quinolin-2-one;TKI-258;CHIR-258(Dovitinib,TKI258);CHIR258 7.7G;CHIR-258(Dovitinib);
分子式:C21H21FN6O
分子量:392.42900
精确质量:392.17600
PSA:94.04000
LOGP:3.12860
物化性质
密度:1.386
安全信息
生产方法及用途
毒性
加载中...